COVID-19 enfeksiyonu, diyabetik ayakta mortaliteyi belirliyor olabilir mi?
Öz
Anahtar Kelimeler
References
- Zhu N, Zhang D, Wang W. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020 Feb 20; 382 (8): 727-733.
- Amraei R, Rahimi N. COVID-19, renin-angiotensin system and endothelial dysfunction. Cells. 2020 Jul 9; 9 (7): 1652.
- Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. 2020 Sep;18 (9): 2103-2109.
- Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15; 395 (10223): 497-506.
- Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020 Mar 17; 323 (11): 1061-1069.
- Freeman E.E, McMahon D.E, Lipoff J.B. The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020 Oct; 83 (4): 1118-1129.
- Baeck M, Herman A. COVID toes: Where do we stand with the current evidence? Int. J. Infect. Dis. 2021 Jan; 102: 53-55
Details
Primary Language
Turkish
Subjects
Health Care Administration
Journal Section
Case Report
Authors
Esma Pehlivan Köroğlu
*
0000-0003-3616-8051
Türkiye
Şevki Çetinkalp
0000-0001-6072-2062
Türkiye
Publication Date
June 30, 2021
Submission Date
April 30, 2021
Acceptance Date
May 6, 2021
Published in Issue
Year 2021 Volume: 60 Number: 2